Understanding Chronic Lymphocytic Leukemia

Recruiting

• Conditions: Chronic Lymphocytic Leukemia

• Registration Number: NCT04028531
• Lead Sponsor: Dana-Farber Cancer Institute

Brief Summary

The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.

Detailed Description

The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia, for the potential development of more effective therapies for this disease.

Study Timeline

• Study Start: 1999-09-29
• Study First Submitted: 2019-06-26
• Study First Submitted QC: 2019-07-19
• Study First Posted: 2019-07-22
• Status Verified: 2025-07
• Last Update Submitted: 2025-07-17
• Last Update Posted: 2025-07-22
• Primary Completion: 2030-09-29
• Study Completion: 2032-09-29

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 2750

Inclusion Criteria

• New and existing patients seen for treatment of monoclonal B-cell lymphocytosis
• Any low grade lymphoproliferative disorder
• Chronic Lymphocytic Leukemia in the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of novel genomic prognostic markers in Chronic Lymphocytic Leukemia	20 years	Exploratory science to better understand Chronic Lymphocytic Leukemia

Trial Locations

Locations (1)

Dana Farber Cancer Institute; 🇺🇸 Boston, Massachusetts, United States